Media Centre
Year-to-date and Q3 2019 Results
AstraZeneca will announce its year-to-date and Q3 2019 Results at 07:00 UK time on Thursday 24 October 2019. You are invited to participate in a media conference webcast or conference call, hosted by CEO Pascal Soriot, starting at 09:00 UK time.
Conference detailsLatest press releases
-
AstraZeneca commits $35m to help young people tackle the threat of non-communicable diseases
-
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes
-
Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer
-
Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen
-
AstraZeneca divests rights for Losec to Cheplapharm
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
